BALBONI, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.788
EU - Europa 515
AS - Asia 365
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.674
Nazione #
US - Stati Uniti d'America 1.787
CN - Cina 218
UA - Ucraina 146
DE - Germania 120
TR - Turchia 98
GB - Regno Unito 71
IT - Italia 59
SE - Svezia 51
SG - Singapore 37
FI - Finlandia 32
PL - Polonia 11
FR - Francia 10
RU - Federazione Russa 4
BE - Belgio 3
CZ - Repubblica Ceca 3
AU - Australia 2
HK - Hong Kong 2
IN - India 2
KR - Corea 2
VN - Vietnam 2
BN - Brunei Darussalam 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 2.674
Città #
Houston 218
Fairfield 211
Woodbridge 196
Jacksonville 167
Chandler 151
Ann Arbor 131
Ashburn 125
Wilmington 80
Cambridge 68
Beijing 64
Seattle 62
Nanjing 54
Izmir 40
Milan 34
Princeton 34
San Diego 25
Bremen 23
Boardman 21
Singapore 18
Shanghai 17
Dearborn 16
Nanchang 16
San Mateo 14
Jinan 11
Shenyang 10
Warsaw 10
Ferrara 8
Los Angeles 7
Zhengzhou 7
Indiana 6
Jiaxing 6
Tianjin 6
Addison 5
Kilburn 5
Mountain View 5
New York 5
Washington 5
Auburn Hills 4
Changsha 4
Norwalk 4
Philadelphia 4
Redwood City 4
Bologna 3
Brussels 3
Falls Church 3
Kunming 3
Acton 2
Antea 2
Cagliari 2
Cosenza 2
Dong Ket 2
Fremont 2
Guangzhou 2
Haikou 2
Hebei 2
Helsinki 2
Hong Kong 2
Ningbo 2
Redmond 2
San Francisco 2
Taizhou 2
Tappahannock 2
Verona 2
Albert Park 1
Amsterdam 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Baotou 1
Canberra 1
Changchun 1
Chicago 1
Des Moines 1
Dublin 1
Düsseldorf 1
Edinburgh 1
Hounslow 1
Jakarta 1
Jinhua 1
Lanzhou 1
Leawood 1
Leipzig 1
London 1
New Bedfont 1
Olomouc 1
Orange 1
Osasco 1
Oslo 1
Prague 1
Prescot 1
Taiyuan 1
Wandsworth 1
Yellow Springs 1
Totale 1.977
Nome #
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 149
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 146
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 140
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 135
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 130
Design of d-opioid peptide antagonists for emerging drug applications 110
Critical role for prokineticin 2 in CNS autoimmunity 109
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 108
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 107
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 96
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 95
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 94
null 90
Tritiation of delta opioid-receptor selective antagonist dipeptide ligands with extraordinary affinity containing 2 ', 6 ' dimethyltyrosine 86
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 83
Design and solution structure of a partially rigid opioid antagonist lacking the basic center - Models of antagonism 79
Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties 77
Conformational analysis of potent and very selective delta opioid dipeptide antagonists 75
Design of μ selective opioid dipeptide antagonists 72
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test amd regulate BDNF mRNA expression in rats. 68
Opioid diketopiperazines: Refinement of the delta opioid antagonist pharmacophore 67
Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist 66
Further Studies on the Dmt-Tic Pharmacophore: Hydrophobic Substituents at the C-Terminus Endow delta Antagonists To Manifest mu Agonism or mu Antagonism 64
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance. 63
Inverse agonism by Dmt-Tic analogues and H5 378, a naltrindole analogue 61
Delta-, but not mu-, opioid receptor stabilize K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia. 61
DMT-TIC-OH, a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse 59
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity 59
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore 54
null 46
Synthesis, metabolic stability and chemotactic activity of peptide T and its analogues 26
Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R ' analogues: Acquisition of potent delta antagonism 15
Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei 9
Totale 2.699
Categoria #
all - tutte 11.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020587 87 12 13 79 36 85 57 59 34 75 40 10
2020/2021386 33 32 8 60 7 39 18 41 11 52 61 24
2021/2022324 8 34 35 21 28 9 14 16 16 21 22 100
2022/2023372 33 8 21 43 73 45 32 41 37 3 16 20
2023/2024173 12 33 13 6 11 37 13 12 1 5 1 29
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 2.699